Our result implied that the lower level of sAxl in IPF patients may lead to an attenuated suppression of Gas6 signal, resulting in increased Axl pathway activation in other cells in lung tissue such as fibroblasts and macrophages. The gene discussed is GAS6; the disease is idiopathic pulmonary fibrosis.